Unique ID issued by UMIN | UMIN000014492 |
---|---|
Receipt number | R000016856 |
Scientific Title | A trial of prospective adjuvant chemotherapy in patients with resectable colorectal cancer with heaptic metastasis |
Date of disclosure of the study information | 2014/07/07 |
Last modified on | 2022/01/11 20:05:51 |
A trial of prospective adjuvant chemotherapy in patients with resectable colorectal cancer with heaptic metastasis
A trial of prospective adjuvant chemotherapy in patients with resectable colorectal cancer with heaptic metastasis
A trial of prospective adjuvant chemotherapy in patients with resectable colorectal cancer with heaptic metastasis
A trial of prospective adjuvant chemotherapy in patients with resectable colorectal cancer with heaptic metastasis
Japan |
Resectable colorectal cancer with hepatic metastasis
Gastrointestinal surgery | Hepato-biliary-pancreatic surgery |
Malignancy
NO
The aim is to evaluate the efficacy and safety of UFT/UZEL as adjuvant chemothrapy for resectable colorectal cancer with hepatic metastasis
Safety,Efficacy
Exploratory
Pragmatic
Phase II
Disease Free Survival
Overall Survival, Relapse Free Survival, Safety, the ratio of the patients who completed the course of UFT/UZEL, Quality of Life
Interventional
Single arm
Non-randomized
Open -no one is blinded
Uncontrolled
1
Treatment
Medicine |
UFT/UZEL
20 | years-old | <= |
80 | years-old | > |
Male and Female
1. Colorectal cancer is hitologically diagnosed
2. Synchronous or metachronous liver metastasis is diagnosed
3. There are no distant metastasis, recurrence except liver on CT within 4 weeks before liver resection
4. Curative resection (R0)is performed
5. The age is between 20 years old and 80 years old at the registration day.
6. Performance status is 0-2 cases.
7. The oral intake of the drug is possible.
8. A major organ function is maintained by a laboratory study within 14 days before registration.
9. An agreement is obtained in a document from the patients.
1. multiple primary cancer
2. Serious postoperative complications
3. Case with the following complications
-Poor control diabetes mellitus
-Poor control hypertention
-Myocardial infarction or unstable angina within six months.
-Interstitial pneumonia, pulmonary fibrosis, severe pulmonary emphysema
4. Case with the following
-A pregnant woman or the women who may be pregnant or hope to be pregnant
-lactating women
5. The patients complicated with psychosis or neurologic manifestation, and judged to have difficulty in participation in clinical trials.
6. The case judged to be unsuitable for registration
40
1st name | |
Middle name | |
Last name | Akinobu Taketomi |
Hokkaido University Graduate School of Medicine
Gastroenterological Surgery I
N-15 W-7, Kita-ku, Sapporo, Japan
011-706-5927
taketomi@med.hokudai.ac.jp
1st name | |
Middle name | |
Last name | Hideki Yokoo |
Hokkaido University Graduate School of Medicine
Gastroenterological Surgery I
15 W-7, Kita-ku, Sapporo, Japan
011-706-5927
hi-yokoo@mua.biglobe.ne.jp
Gastroenterological Surgery I, Hokkaido University Graduate School of Medicine
Hokkaido University Hospital
Other
NO
2014 | Year | 07 | Month | 07 | Day |
Unpublished
No longer recruiting
2012 | Year | 08 | Month | 28 | Day |
2012 | Year | 09 | Month | 10 | Day |
2012 | Year | 09 | Month | 10 | Day |
2014 | Year | 06 | Month | 30 | Day |
2014 | Year | 07 | Month | 07 | Day |
2022 | Year | 01 | Month | 11 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000016856